Sonendo, Inc. (SONX): Price and Financial Metrics
GET POWR RATINGS... FREE!
SONX Stock Price Chart Interactive Chart >
SONX Price/Volume Stats
| Current price | $1.77 | 52-week high | $12.24 |
| Prev. close | $1.69 | 52-week low | $1.66 |
| Day low | $1.66 | Volume | 20,915 |
| Day high | $1.77 | Avg. volume | 133,520 |
| 50-day MA | $2.44 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 46.78M |
Sonendo, Inc. (SONX) Company Bio
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software that integrates digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.
Latest SONX News From Around the Web
Below are the latest news stories about Sonendo Inc that investors may wish to consider to help them evaluate SONX as an investment opportunity.
What Type Of Shareholders Own The Most Number of Sonendo, Inc. (NYSE:SONX) Shares?If you want to know who really controls Sonendo, Inc. ( NYSE:SONX ), then you'll have to look at the makeup of its... |
Sonendo hot streak continues for a third day as shares up 11%Sonendo shares are up today continuing an upward trend that began on Monday. |
Sonendo estimates prelim Q4 revenueSonendo (SONX) expects to report revenue in the range of $9.7 to $9.9M for Q4; product revenue is expected to be in the range of $7.5 to $7.7M and software revenue is seen at |
Sonendo, Inc. Announces Preliminary Revenue Results for the Fourth Quarter and Full-Year 2021LAGUNA HILLS, Calif., January 10, 2022--Sonendo, Inc. ("Sonendo") (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced certain unaudited preliminary revenue results for the fourth quarter and full-year ended December 31, 2021. |
Reviewing BIOLASE (NASDAQ:BIOL) and Sonendo (NYSE:SONX)BIOLASE (NASDAQ:BIOL) and Sonendo (NYSE:SONX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, institutional ownership, earnings, profitability and dividends. Insider & Institutional Ownership 11.7% of BIOLASE shares are owned by institutional investors. 2.8% of BIOLASE shares [] |
SONX Price Returns
| 1-mo | -27.76% |
| 3-mo | -42.53% |
| 6-mo | -68.56% |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -69.27% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...